ATE257014T1 - Lichtbilderzeugungskontrastmitteln - Google Patents

Lichtbilderzeugungskontrastmitteln

Info

Publication number
ATE257014T1
ATE257014T1 AT98919335T AT98919335T ATE257014T1 AT E257014 T1 ATE257014 T1 AT E257014T1 AT 98919335 T AT98919335 T AT 98919335T AT 98919335 T AT98919335 T AT 98919335T AT E257014 T1 ATE257014 T1 AT E257014T1
Authority
AT
Austria
Prior art keywords
light imaging
imaging contrast
contrast agents
molecular weight
range
Prior art date
Application number
AT98919335T
Other languages
English (en)
Inventor
Robert Allen Snow
Paul Mark Henrichs
Daniel Joseph Nycomed Delecki
William A Sanderson
Vinay Chandrakant Desai
Edward Bacon
Kenneth R Hollister
Eric Paul Hohenschuh
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9727124.1A external-priority patent/GB9727124D0/en
Application filed by Amersham Health As filed Critical Amersham Health As
Application granted granted Critical
Publication of ATE257014T1 publication Critical patent/ATE257014T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyethers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98919335T 1997-04-29 1998-04-28 Lichtbilderzeugungskontrastmitteln ATE257014T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84858697A 1997-04-29 1997-04-29
GBGB9727124.1A GB9727124D0 (en) 1997-12-22 1997-12-22 Compounds
US3528598A 1998-03-05 1998-03-05
PCT/GB1998/001244 WO1998048838A1 (en) 1997-04-29 1998-04-28 Compounds

Publications (1)

Publication Number Publication Date
ATE257014T1 true ATE257014T1 (de) 2004-01-15

Family

ID=27269147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98919335T ATE257014T1 (de) 1997-04-29 1998-04-28 Lichtbilderzeugungskontrastmitteln

Country Status (8)

Country Link
US (1) US6350431B1 (de)
EP (1) EP0979103B1 (de)
JP (1) JP4699575B2 (de)
AT (1) ATE257014T1 (de)
AU (2) AU7221398A (de)
DE (1) DE69820867T2 (de)
ES (1) ES2213899T3 (de)
WO (2) WO1998048838A1 (de)

Families Citing this family (170)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2326322C (en) * 1998-04-21 2011-03-01 University Of Connecticut Free-form nanofabrication using multi-photon excitation
GB2337523A (en) * 1998-04-29 1999-11-24 Nycomed Imaging As Light imaging contrast agents
CA2335808A1 (en) * 1998-07-06 2000-01-13 David Kessel Intracellular sensitizers for sonodynamic therapy
US6986740B2 (en) * 1998-11-02 2006-01-17 Xantech Pharmaceuticals, Inc. Ultrasound contrast using halogenated xanthenes
GB9824632D0 (en) * 1998-11-10 1999-01-06 Celltech Therapeutics Ltd Biological compounds
SE9804328D0 (sv) * 1998-12-15 1998-12-15 Christer Busch Contrast agent for facilitating ocular identification and inspection of lymph nodes
US6167297A (en) * 1999-05-05 2000-12-26 Benaron; David A. Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
US6217848B1 (en) 1999-05-20 2001-04-17 Mallinckrodt Inc. Cyanine and indocyanine dye bioconjugates for biomedical applications
AU769853B2 (en) * 1999-06-11 2004-02-05 Atossa Genetics, Inc. Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
EP1202671A4 (de) 1999-08-13 2004-11-10 Point Biomedical Corp Mikropartikel verwendbar als ultraschallkontrastmittel für das lymphsystem
EP1088559A3 (de) * 1999-09-29 2002-10-02 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN Galenische Formulierungen
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6750037B2 (en) 1999-12-27 2004-06-15 Edwin L. Adair Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
US6395257B1 (en) * 2000-01-18 2002-05-28 Mallinckrodt Inc. Dendrimer precursor dyes for imaging
US7790144B2 (en) 2000-01-18 2010-09-07 Mallinckrodt Inc. Receptor-avid exogenous optical contrast and therapeutic agents
JP2001299676A (ja) * 2000-04-25 2001-10-30 Fuji Photo Film Co Ltd センチネルリンパ節検出方法および検出システム
JP2002095663A (ja) * 2000-09-26 2002-04-02 Fuji Photo Film Co Ltd センチネルリンパ節光断層画像取得方法および装置
EP1801165B1 (de) 2000-09-29 2012-08-01 Life Technologies Corporation Modifizierte Carbocyanin-Farbstoffe und ihre Konjugate
AU2001294859A1 (en) 2000-09-29 2002-04-08 Molecular Probes, Inc. Modified carbocyanine dyes and their conjugates
US7556797B2 (en) 2000-10-16 2009-07-07 Mallinckrodt Inc. Minimally invasive physiological function monitoring agents
US6733744B1 (en) * 2000-10-16 2004-05-11 Mallinckrodt Inc. Indole compounds as minimally invasive physiological function monitoring agents
US6656451B1 (en) * 2000-10-16 2003-12-02 Mallinckrodt, Inc. Indole compounds as novel dyes for organ function monitoring
WO2002038190A2 (en) 2000-10-27 2002-05-16 Beth Israel Deaconess Medical Center Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
AU2002230842A1 (en) 2000-10-30 2002-05-15 The General Hospital Corporation Optical methods and systems for tissue analysis
US9295391B1 (en) 2000-11-10 2016-03-29 The General Hospital Corporation Spectrally encoded miniature endoscopic imaging probe
US9897538B2 (en) 2001-04-30 2018-02-20 The General Hospital Corporation Method and apparatus for improving image clarity and sensitivity in optical coherence tomography using dynamic feedback to control focal properties and coherence gating
US20060148683A1 (en) * 2001-10-16 2006-07-06 Mcmurry Thomas J Detection and treatment of intravascular lesions
US6980299B1 (en) 2001-10-16 2005-12-27 General Hospital Corporation Systems and methods for imaging a sample
US20030105300A1 (en) 2001-10-17 2003-06-05 Mallinckrodt Inc. Tumor targeted photodiagnostic-phototherapeutic agents
US6761878B2 (en) 2001-10-17 2004-07-13 Mallinckrodt, Inc. Pathological tissue detection and treatment employing targeted benzoindole optical agents
DE60232184D1 (de) * 2001-12-28 2009-06-10 Prysmian Spa Wasserbeständiges telekommunikations kabel
EP2290318B1 (de) 2002-01-11 2015-08-26 The General Hospital Corporation OCT Einrichtung mit axialem Linienfokus für verbesserte Auflösung und Tiefenschärfe
US7355716B2 (en) 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
WO2003079015A1 (en) * 2002-03-11 2003-09-25 Visen Medical, Inc. Optical imaging probes
IL164362A0 (en) * 2002-04-02 2005-12-18 Yeda Res & Dev Characterization of moving objects in a stationarybackground
US20040121405A1 (en) * 2002-04-16 2004-06-24 Green Bernard S. Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
US20030225448A1 (en) * 2002-05-28 2003-12-04 Scimed Life Systems, Inc. Polar radiopaque marker for stent
US7144950B2 (en) * 2003-09-17 2006-12-05 The Regents Of The University Of California Conformationally flexible cationic conjugated polymers
US9371559B2 (en) 2002-06-20 2016-06-21 The Regents Of The University Of California Compositions for detection and analysis of polynucleotides using light harvesting multichromophores
US10001475B2 (en) 2002-06-20 2018-06-19 The Regents Of The University Of California Light harvesting multichromophore compositions and methods of using the same
DE60307545T2 (de) * 2002-06-21 2007-10-04 Adair, Edwin L., Castle Pines Village Anwendung von Metalloporphyrinen zur Behandlung von Arteriosklerose
EP1606291A2 (de) * 2002-07-02 2005-12-21 Health Research, Inc. Effiziente synthese von pyropheophorbid-a und seiner derivate
EA007653B1 (ru) 2002-08-26 2006-12-29 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Способы и композиции обнаружения и анализа полинуклеотидов с помощью светособирающих полихромофоров
US20040115754A1 (en) * 2002-12-11 2004-06-17 Umax Data Systems Inc. Method for establishing a long-term profile of blood sugar level aiding self-control of the same
TW200411178A (en) * 2002-12-31 2004-07-01 Veutron Corp Method for determining the resolution of blood glucose by using rising time curve
TWI309571B (en) * 2002-12-31 2009-05-11 Ind Tech Res Inst Delivery carrier for targeting cells haring over-expressed estrogen
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7643153B2 (en) 2003-01-24 2010-01-05 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
DE602004024038D1 (de) * 2003-02-13 2009-12-24 Univ California Verfahren und zusammensetzungen zum nachweis und zur analyse von polynukleotidbindungsproteinwechselwirkungen unter verwendung licht sammelnder multichromophoren
JP2004269439A (ja) * 2003-03-10 2004-09-30 Motohiro Takeda センチネルリンパ節検出剤及び検出方法
CA2519937C (en) 2003-03-31 2012-11-20 Guillermo J. Tearney Speckle reduction in optical coherence tomography by path length encoded angular compounding
TW592667B (en) * 2003-04-04 2004-06-21 Veutron Corp Method for determining the resolution of blood glucose
WO2005000218A2 (en) 2003-05-31 2005-01-06 Washington University Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
EP2280257B1 (de) 2003-06-06 2017-04-05 The General Hospital Corporation Verfahren und Vorrichtung für eine Lichtquelle mit Abstimmung der Wellenlänge
US7332477B2 (en) * 2003-07-10 2008-02-19 Nitto Denko Corporation Photocleavable DNA transfer agent
JP4586022B2 (ja) * 2003-09-29 2010-11-24 日東電工株式会社 インビボポリヌクレオチド送達用生分解性ポリアセタール
EP3009815B1 (de) 2003-10-27 2022-09-07 The General Hospital Corporation Verfahren und vorrichtung zur durchführung optischer abbildung mit frequenzdomäneninterferometrie
US7551293B2 (en) 2003-11-28 2009-06-23 The General Hospital Corporation Method and apparatus for three-dimensional spectrally encoded imaging
US20050171424A1 (en) * 2004-01-13 2005-08-04 The Gov. Of The Usa As Rep. By The Secretary Of The Dept. Of Health And Human Services Methods for imaging the lymphatic system using dendrimer-based contrast agents
US7302846B2 (en) * 2004-03-12 2007-12-04 Hadala Anthony J Temperature-sensing device for determining the level of a fluid
WO2006009786A2 (en) * 2004-06-18 2006-01-26 Elmaleh David R Intravascular imaging device and uses thereof
US20080193377A1 (en) * 2004-06-28 2008-08-14 University Of Maryland, Baltimore Radiolabeled Nanohybrids Targeting Solid Tumor Neovasculature and Method of Using Same
WO2006014392A1 (en) 2004-07-02 2006-02-09 The General Hospital Corporation Endoscopic imaging probe comprising dual clad fibre
US8081316B2 (en) 2004-08-06 2011-12-20 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US8208995B2 (en) 2004-08-24 2012-06-26 The General Hospital Corporation Method and apparatus for imaging of vessel segments
JP5334415B2 (ja) 2004-08-24 2013-11-06 ザ ジェネラル ホスピタル コーポレイション 試料の機械的歪み及び弾性的性質を測定するプロセス、システム及びソフトウェア
JP5215664B2 (ja) 2004-09-10 2013-06-19 ザ ジェネラル ホスピタル コーポレイション 光学コヒーレンス撮像のシステムおよび方法
EP2329759B1 (de) 2004-09-29 2014-03-12 The General Hospital Corporation System und Verfahren zur Abbildung optischer Kohärenz
EP1655040A1 (de) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Kontrastmittel Zusammensetzungen für die Bildgebung des Lymphsystems
US7382949B2 (en) 2004-11-02 2008-06-03 The General Hospital Corporation Fiber-optic rotational device, optical system and method for imaging a sample
JP4597744B2 (ja) 2004-11-08 2010-12-15 株式会社トプコン 光画像計測装置及び光画像計測方法
EP1816949A1 (de) 2004-11-29 2007-08-15 The General Hospital Corporation Anordnungen, vorrichtungen, endoskope, katheter und verfahren für die optische bilddarstellung durch gleichzeitige beleuchtung und nachweis von mehreren punkten auf einer probe
EP2502946B1 (de) 2005-01-10 2017-10-04 The Regents of The University of California Kationische konjugierte Polymere zur faserspezifischen Polynukleotid-Erkennung in homogenen Festkörper-Testanordnungen
US7811755B2 (en) * 2005-01-10 2010-10-12 The Regents Of The University Of California Methods and articles for strand-specific polynucleotide detection with cationic multichromophores
WO2006083932A2 (en) 2005-01-31 2006-08-10 The Regents Of The University Methods and compositions for aggregant detection
US20060204443A1 (en) * 2005-03-11 2006-09-14 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods for tumor treatment using dendrimer conjugates
US7674452B2 (en) * 2005-03-16 2010-03-09 Nitto Denko Corporation Polymer coating of cells
US7432027B2 (en) * 2005-03-30 2008-10-07 Xerox Corporation Dual-layer protected transient document
EP1875436B1 (de) 2005-04-28 2009-12-09 The General Hospital Corporation Bewertung von bildmerkmalen einer anatomischen struktur in optischen kohärenztomographiebildern
JP2008539905A (ja) * 2005-05-06 2008-11-20 エダ リサーチ アンド ディベロップメント カンパニー，リミティド 心臓周期に関連する血管における赤血球の運動の撮像および分析
WO2007041382A1 (en) 2005-09-29 2007-04-12 General Hospital Corporation Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures
WO2007084995A2 (en) 2006-01-19 2007-07-26 The General Hospital Corporation Methods and systems for optical imaging of epithelial luminal organs by beam scanning thereof
US8145018B2 (en) 2006-01-19 2012-03-27 The General Hospital Corporation Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements
EP1986545A2 (de) 2006-02-01 2008-11-05 The General Hospital Corporation Vorrichtung zur anwendung mehrerer elektromagnetischer strahlungen auf einer probe
EP1983921B1 (de) 2006-02-01 2016-05-25 The General Hospital Corporation Systeme zur bereitstellung elektromagnetischer strahlung für mindestens einen teil einer probe mittels konformer lasertherapieverfahren
EP1986562B1 (de) 2006-02-01 2015-04-08 The General Hospital Corporation Vorrichtung zur steuerung mindestens einer von mindestens zwei sektionen mindestens einer faser
EP3143926B1 (de) 2006-02-08 2020-07-01 The General Hospital Corporation Verfahren, anordnungen und systeme zum abrufen von informationen im zusammenhang mit einer anatomischen probe mithilfe eines optischen mikroskops
JP2009527770A (ja) 2006-02-24 2009-07-30 ザ ジェネラル ホスピタル コーポレイション 角度分解型のフーリエドメイン光干渉断層撮影法を遂行する方法及びシステム
NZ570693A (en) * 2006-03-20 2011-02-25 Pfizer Ltd Amine derivatives
WO2007124459A2 (en) * 2006-04-20 2007-11-01 Inphase Technologies, Inc. Index-contrasting-photoactive polymerizable materials, and articles and methods using same
EP2015669A2 (de) 2006-05-10 2009-01-21 The General Hospital Corporation Verfahren, anordnungen und systeme für frequenzbereichsabbildung einer probe
US20070297988A1 (en) * 2006-06-21 2007-12-27 Bin Wu Optical probes for in vivo imaging
WO2008006006A1 (en) 2006-07-03 2008-01-10 Beth Israel Deaconess Medical Center, Inc. Histology methods
US8158444B2 (en) 2006-10-06 2012-04-17 Sirigen, Inc. Fluorescent methods and materials for directed biomarker signal amplification
US8838213B2 (en) 2006-10-19 2014-09-16 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s)
WO2008102065A1 (fr) * 2007-02-14 2008-08-28 Commissariat A L'energie Atomique Emulsions fluorescentes pour l'imagerie optique
EP2132840A2 (de) 2007-03-23 2009-12-16 The General Hospital Corporation Verfahren, anordnungen und vorrichtung zur verwendung eines wellenlängengewobbelten lasers anhand von winkelabtastungs und dispersionsverfahren
WO2008121844A1 (en) 2007-03-30 2008-10-09 The General Hospital Corporation System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque
JP5917803B2 (ja) 2007-07-31 2016-05-18 ザ ジェネラル ホスピタル コーポレイション 高速ドップラー光周波数領域撮像法のためのビーム走査パターンを放射するシステムおよび方法
US20090062724A1 (en) * 2007-08-31 2009-03-05 Rixen Chen System and apparatus for sonodynamic therapy
US8403862B2 (en) * 2007-12-20 2013-03-26 Yeda Research And Development Co. Ltd. Time-based imaging
US9332942B2 (en) 2008-01-28 2016-05-10 The General Hospital Corporation Systems, processes and computer-accessible medium for providing hybrid flourescence and optical coherence tomography imaging
US11123047B2 (en) 2008-01-28 2021-09-21 The General Hospital Corporation Hybrid systems and methods for multi-modal acquisition of intravascular imaging data and counteracting the effects of signal absorption in blood
US20110020228A1 (en) * 2008-02-01 2011-01-27 University Of Florida Resarch Foundation, Inc. Targeted cellular selectivity of surface active molecules
US20090214436A1 (en) 2008-02-18 2009-08-27 Washington University Dichromic fluorescent compounds
EP2288948A4 (de) 2008-06-20 2011-12-28 Gen Hospital Corp Anordnung aus kondensierten glasfaserkopplern und verfahren zu ihrer verwendung
US9254089B2 (en) 2008-07-14 2016-02-09 The General Hospital Corporation Apparatus and methods for facilitating at least partial overlap of dispersed ration on at least one sample
FR2935001B1 (fr) * 2008-08-14 2011-12-30 Commissariat Energie Atomique Emulsion fluorescente
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
US20100098637A1 (en) * 2008-09-23 2010-04-22 The Regents Of The University Of Michigan Dye-loaded nanoparticle
ES2957932T3 (es) 2008-12-10 2024-01-30 Massachusetts Gen Hospital Sistemas, aparatos y procedimientos para ampliar el rango de profundidad de imagen de tomografía de coherencia óptica mediante submuestreo óptico
JP6053284B2 (ja) 2009-02-04 2016-12-27 ザ ジェネラル ホスピタル コーポレイション ハイスピード光学波長チューニング源の利用のための装置及び方法
WO2010105197A2 (en) 2009-03-12 2010-09-16 The General Hospital Corporation Non-contact optical system, computer-accessible medium and method for measuring at least one mechanical property of tissue using coherent speckle techniques(s)
US20120114563A1 (en) 2009-03-19 2012-05-10 General Electric Company Optical imaging agents
WO2010135666A1 (en) * 2009-05-22 2010-11-25 Vanderbilt University Bimodal star polymer architectures as fluorescent and mri imaging reagents
SG177355A1 (en) 2009-06-26 2012-02-28 Sirigen Inc Signal amplified biological detection with conjugated polymers
EP2453791B1 (de) 2009-07-14 2023-09-06 The General Hospital Corporation Vorrichtung zum messen des flusses und drucks in einem gefäss
WO2011035140A1 (en) 2009-09-18 2011-03-24 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of contrast moieties to the lungs
TWI391144B (zh) * 2009-10-26 2013-04-01 Iner Aec Executive Yuan 一種定量肝殘餘功能的檢驗方法與其新穎肝受體造影檢驗藥劑
JP6073684B2 (ja) 2010-01-19 2017-02-01 シリゲン セカンド リミテッド 指向性バイオマーカーシグナル増幅のための新規の試薬
US8896838B2 (en) 2010-03-05 2014-11-25 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US8772443B2 (en) 2010-03-26 2014-07-08 Hitachi Chemical Co., Ltd. Water soluble near infrared sensing polymers with low band gaps
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
US9795301B2 (en) 2010-05-25 2017-10-24 The General Hospital Corporation Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images
US9557154B2 (en) 2010-05-25 2017-01-31 The General Hospital Corporation Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions
CN103038629B (zh) * 2010-05-31 2015-07-08 卫材R&D管理有限公司 淋巴结成像用荧光探针
EP2575591A4 (de) 2010-06-03 2017-09-13 The General Hospital Corporation Vorrichtung und verfahren für geräte zur abbildung von strukturen in oder an einem oder mehreren lumenorganen
JP5947795B2 (ja) 2010-09-10 2016-07-06 日立化成株式会社 個別にアドレス可能なバンド電極アレイ及びそれを製造する方法
GB201015806D0 (en) 2010-09-21 2010-10-27 Ge Healthcare As Vascular imaging agents
EP2632324A4 (de) 2010-10-27 2015-04-22 Gen Hospital Corp Vorrichtungen, systeme und verfahren zur blutdruckmessung in mindestens einem gefäss
US20120121518A1 (en) * 2010-11-16 2012-05-17 Zhihua Lu Multifunctional imaging and therapeutic nanoparticles
US9052289B2 (en) 2010-12-13 2015-06-09 Schlumberger Technology Corporation Hydrogen sulfide (H2S) detection using functionalized nanoparticles
EP3029027B1 (de) 2010-12-21 2018-06-27 Pierce Biotechnology, Inc. Fluoreszierende verbindungen
US8889884B1 (en) 2011-07-14 2014-11-18 Pierce Biotechnology, Inc. Phosphine derivatives of fluorescent compounds
JP2014523536A (ja) 2011-07-19 2014-09-11 ザ ジェネラル ホスピタル コーポレイション 光コヒーレンストモグラフィーにおいて偏波モード分散補償を提供するためのシステム、方法、装置およびコンピュータアクセス可能な媒体
US9249307B2 (en) 2011-08-16 2016-02-02 Pierce Biotechnology, Inc. Benzocyanine compounds
EP2748587B1 (de) 2011-08-25 2021-01-13 The General Hospital Corporation Verfahren und anordnungen zur bereitstellung mikrooptischer kohärenztomographieverfahren
US8965062B2 (en) 2011-09-16 2015-02-24 The Invention Science Fund I, Llc Reporting imaged portions of a patient's body part
GB201116733D0 (en) 2011-09-28 2011-11-09 Ge Healthcare As Peptide margin imaging agents
US9341783B2 (en) 2011-10-18 2016-05-17 The General Hospital Corporation Apparatus and methods for producing and/or providing recirculating optical delay(s)
EP3553075B1 (de) 2012-01-23 2025-01-08 Washington University Brillenbildgebungssysteme und -verfahren
US9751868B2 (en) 2012-02-28 2017-09-05 Pierce Biotechnology, Inc. Benzocyanine compounds
US20140072515A9 (en) 2012-03-02 2014-03-13 Greg Hermanson Cyanine compounds
EP2833776A4 (de) 2012-03-30 2015-12-09 Gen Hospital Corp Abbildungssystem, verfahren und distaler anschluss zur multidirektionalen sichtfeldendoskopie
WO2013177154A1 (en) 2012-05-21 2013-11-28 The General Hospital Corporation Apparatus, device and method for capsule microscopy
CN104470546B (zh) 2012-07-20 2018-02-27 佳能株式会社 化合物和含有所述化合物的光声成像造影剂
US9415550B2 (en) 2012-08-22 2016-08-16 The General Hospital Corporation System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography
US9676787B2 (en) 2012-08-28 2017-06-13 Pierce Biotechnology, Inc. Benzopyrylium compounds
US10893806B2 (en) 2013-01-29 2021-01-19 The General Hospital Corporation Apparatus, systems and methods for providing information regarding the aortic valve
WO2014121082A1 (en) 2013-02-01 2014-08-07 The General Hospital Corporation Objective lens arrangement for confocal endomicroscopy
JP6378311B2 (ja) 2013-03-15 2018-08-22 ザ ジェネラル ホスピタル コーポレイション 物体を特徴付ける方法とシステム
US9784681B2 (en) 2013-05-13 2017-10-10 The General Hospital Corporation System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence
CA2912949C (en) 2013-05-24 2021-07-27 University Health Network Novel multimodal ct/optical agents
US10117576B2 (en) 2013-07-19 2018-11-06 The General Hospital Corporation System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina
EP4349242A3 (de) 2013-07-19 2024-06-19 The General Hospital Corporation Bildgebungsvorrichtung und verfahren mit multidirektionaler sichtfeldendoskopie
EP3025173B1 (de) 2013-07-26 2021-07-07 The General Hospital Corporation Vorrichtung mit optische dispersion nutzender laseranordnung zur anwendung in der fourier-raum optischen kohärenztomographie
WO2015105870A1 (en) 2014-01-08 2015-07-16 The General Hospital Corporation Method and apparatus for microscopic imaging
WO2015116986A2 (en) 2014-01-31 2015-08-06 The General Hospital Corporation System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device
US10228556B2 (en) 2014-04-04 2019-03-12 The General Hospital Corporation Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s)
KR102513779B1 (ko) 2014-07-25 2023-03-24 더 제너럴 하스피탈 코포레이션 생체 내 이미징 및 진단을 위한 장치, 디바이스 및 방법
US10806804B2 (en) 2015-05-06 2020-10-20 Washington University Compounds having RD targeting motifs and methods of use thereof
WO2017218764A1 (en) * 2016-06-16 2017-12-21 Beloteca, Inc. Method for preparation of isosulfan blue
CN110506035B (zh) 2018-03-16 2022-08-12 株式会社东芝 生物降解性化合物、脂质粒子、含有脂质粒子的组合物、和试剂盒
CA3135291A1 (en) * 2019-03-29 2020-10-08 The Brigham And Women's Hospital, Inc. Targeted synergistic cancer immunotherapy
CN109966267A (zh) * 2019-05-06 2019-07-05 上海师范大学 纳米声敏剂在制备基于光声引导的声动力学治疗肿瘤药物中的用途
EP4072598A4 (de) 2019-12-13 2024-02-21 Washington University Nahinfrarot-fluoreszierende farbstoffe, formulierungen und zugehörige verfahren
EP4337221A4 (de) * 2021-05-10 2025-06-18 University of Mississippi Farbstoffe auf silikonbasis und verfahren zur herstellung und verwendung davon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5622685A (en) 1990-05-30 1997-04-22 Deutches Krebsforchunszentrum Stiftung Des Offentlichen Rechts Polyether-substituted porphyrin anti-tumor agents
JP2640293B2 (ja) * 1990-05-30 1997-08-13 ドイチエス クレープスフオルシユングスツエントルム ステイフツング デス アフエントリヒエン レヒトス ポリエーテル置換抗腫瘍剤
DE4017439C2 (de) * 1990-05-30 1994-06-23 Deutsches Krebsforsch Polyethersubstituierte Tumormittel
WO1992000748A1 (en) * 1990-07-06 1992-01-23 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5155149A (en) * 1991-10-10 1992-10-13 Boc Health Care, Inc. Silicone polyurethane copolymers containing oxygen sensitive phosphorescent dye compounds
US5508289A (en) * 1994-03-14 1996-04-16 The United States America As Represented By The Department Of Health And Human Services Bis-acridone chemotherapeutic derivatives
DE19539409C2 (de) * 1995-10-11 1999-02-18 Diagnostikforschung Inst Kontrastmittel für die Nahinfrarot-Diagnostik
US5709845A (en) * 1996-05-13 1998-01-20 Rajagopalan; Raghavan Tricyclic functional dyes for contrast enhancement in optical imaging

Also Published As

Publication number Publication date
DE69820867T2 (de) 2004-11-18
JP2002504894A (ja) 2002-02-12
WO1998048838A8 (en) 2000-04-27
AU7221298A (en) 1998-11-24
US6350431B1 (en) 2002-02-26
EP0979103B1 (de) 2004-01-02
DE69820867D1 (de) 2004-02-05
WO1998048838A1 (en) 1998-11-05
WO1998048845A1 (en) 1998-11-05
JP4699575B2 (ja) 2011-06-15
ES2213899T3 (es) 2004-09-01
AU7221398A (en) 1998-11-24
EP0979103A1 (de) 2000-02-16

Similar Documents

Publication Publication Date Title
DE69820867D1 (de) Lichtbilderzeugungskontrastmitteln
DE69503003D1 (de) Perfluoropolyether Schmiermittelzusammensetzungen
ITTO950777A0 (it) Misura di impedenza transvalvolare adatta all'uso in dispositivi im- piantabili.
ITRM920476A1 (it) Formulazioni galeniche contenenti ciclosporina.
TR199802216T2 (xx) Temizleme bile�imleri.
ZA200004285B (en) Poly(alkylene arylates) having optical properties.
DE69405785D1 (de) Fluorosiloxantrennmittelzusammensetzungen
PL343607A1 (en) Poly(alkylene arylates) having optical properties
IT1282402B1 (it) Composizioni acquose di tensioattivi ad elevata viscosita'
ITBO940223A0 (it) Iniettore ad alta capacita' di atomazione.
IT1252605B (it) Copoliesteri aventi una migliorata combinazione di proprieta'.
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
DK1073447T3 (da) N1-modificerede glycopeptider
IT1280845B1 (it) "tavola allungabile"
FI943069A7 (fi) Kloorittomia, mahdollisesti vetypitoisia fluorihiilivetyjä sisältävät koostumukset
FR2695297B1 (fr) Composition d'agent désinfectant.
ITMI942225A0 (it) "gabbia di laminazione orizzontale-verticale"
EP0866709A4 (de) 1,2,4-benzotriazinoxid-formulierungen
IT1270961B (it) Composizioni poliestere ad elevata viscosita'
ATE290538T1 (de) Zusammensetzungen enthaltendes biologisch aktives silizium
IT1272346B (it) "accessorio di raccordo".
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
IT1292763B1 (it) Involucro sterile per la protezione di apparecchi medicali durante l'uso.
BR0003216A (pt) Pó de vidro e uso do mesmo
ITRO970008A1 (it) Inopera - e' un applicativo per la gestione di agenzie immobiliari.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties